42,15 €
0,99 % vorgestern
L&S, 24. Oktober, 22:55 Uhr
ISIN
US4330001060
Symbol
HIMS
Berichte

Hims & Hers Health Inc. Aktie News

Positiv
WSJ
11 Tage alt
The company expects the new specialty to help the Hers unit to surpass $1 billion in annual revenue next year.
Neutral
Business Wire
11 Tage alt
SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (NYSE: HIMS), the leading health and wellness platform, today announced the launch of a new specialty in women's health, offering access to affordable treatment plans built specifically for women experiencing perimenopause and menopause. Starting today, women can work with a provider on the platform to access treatment plans tailored to t...
Positiv
WSJ
11 Tage alt
Hims & Hers Health said it is now providing menopause care, marking the company's latest push into hormone-replacement therapies.
Neutral
The Motley Fool
12 Tage alt
These two healthcare companies are interesting choices for long-term investors, but only one can be the better investment in this comparison.
Neutral
Business Wire
12 Tage alt
SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the leading health and wellness platform, today announced that it will report third quarter 2025 financial results after the market closes on Monday, November 3, 2025. The company will host a live conference call to discuss the results at 5:00 p.m. ET the same day. The conference call can be accessed by dialin...
Positiv
Seeking Alpha
13 Tage alt
I see a clear path for Hims & Hers Health to reach $100 a share, and I plan to be there when it gets there. HIMS expects revenue growth to rebound, driven by weight loss and new health offerings, aiming for 30%+ growth in 2026. Despite a temporary dip into negative free cash flow, HIMS maintains strong profitability targets and trades at an attractive 24x forward free cash flow.
Negativ
Investors Business Daily
16 Tage alt
This options trade set up a potential buying of volatile Hims & Hers Health stock at a discount.
Neutral
Business Wire
17 Tage alt
SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (NYSE: HIMS) today published a new white paper - Understanding Hims & Hers Approach to Clinical Excellence, Quality, and Safety - detailing how rigorous standards, continuous monitoring, and customer-centered design are shaping the future of safe and effective telehealth. “At Hims & Hers, we believe that digital healthcare must be both ac...
Mehr News anzeigen

Kostenlos registrieren

aktien.guide ist das Tool zum einfachen Finden, Analysieren und Beobachten von Aktien. Lerne von erfolgreichen Investoren und triff fundierte Anlageentscheidungen. Wir machen Dich zum selbstbestimmten Investor.

Die Apple Aktie im Überblick mit Charts, aktuellen Kennzahlen, Nachrichten und Aktienanalysen.
Die besten Dividenden-Aktien in der Dividenden-Topscorer-Liste.
Aktienanalysen der besten Aktien weltweit.
Jetzt Vermögen aufbauen